Back to
Point72 Asset Management, L.P.
CBIO3 quarters
Position history for
Point72 Asset Management, L.P.'s holdings in CRESCENT BIOPHARMA INC. COM
Yes. Point72 Asset Management holds 300,000 shares of CBIO (Crescent Biopharma), worth $5.4M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Point72 Asset Management has held CBIO since Q4 2025, across 3 quarterly 13F filings.
Current Value
$5.4M
Current Shares
300,000
Total Value Change
+$1.8M
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CBIO: FMR LLC, BALYASNY ASSET MANAGEMENT L.P.